Renewable hydrocarbons (naphtha type fraction)

Endpoint summary

Description of key information

No repeated toxicity studies have been conducted for the substance, since no representative sample is currently available
In a subchronic inhalation toxicity test conducted for the read-across substance, the systemic NOAEC was greater than 20 000 mg/m3 and the local NOAEC was 10 000 mg/m3 based on the red nasal discharge in animals exposed to 20 000 mg/m³ of vapour.

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion

Endpoint conclusion:

no study available

Repeated dose toxicity: inhalation - systemic effects

Link to relevant study records

Reference

Endpoint:

sub-chronic toxicity: inhalation

Type of information:

read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

weight of evidence

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: see 'Remark'

Remarks:

Acceptable, well-documented study report similar or equivalent to OECD 413 conducted according to the GLP, but conducted for the read-across substance. Read-across justification: Based on the chemical composition, the renewable hydrocarbons obtained from the catalytic hydrotreatment of wood oil with or without the addition of vegetable oils and/or animal fats have similar hydrocarbon fractions and they contain the same critical constituents than fossil fuels (low boiling naphthas). Naphtha is a generic term used to describe volatile, flammable hydrocarbon fractions. The target substance and the sources substances (naphthas) meet same physical-chemical and technical performance specifications in Europe (EN 228). These fuel specifications include limits for the certain properties (vapour pressure and boiling point) which are also important considering the similarities in the toxicological profiles and the toxicokinetic behaviour as well as the relevant exposure routes of the substance. Based on the content of saturated, olefinic and aromatic hydrocarbons, the typical carbon number range and the physicochemical properties, the renewable hydrocarbons with gasoline type fractions can be considered as having structural similarities and similar behaviour in contact with water and in the physiological processes than the analogue source substances (fossil gasolines). Their irritation and skin sensitisation as well as acute and long-term adverse effects to human health is similar. Therefore, and in order to avoid the unnecessary animal testing, the read-across data from the analogue fossil gasolines is used to evaluate the irritation, sensitisation and short term and/or long-term toxicological effects of the target substance.

Justification for type of information:

Based on the chemical composition, the renewable hydrocarbons obtained from the catalytic hydrotreatment of wood oil with or without the addition of vegetable oils and/or animal fats have similar hydrocarbon fractions and they contain the same critical constituents than fossil fuels (low boiling naphthas). Naphtha is a generic term used to describe volatile, flammable hydrocarbon fractions. The target substance and the sources substances (naphthas) meet same physical-chemical and technical performance specifications in Europe (EN 228). These fuel specifications include limits for the certain properties (vapour pressure and boiling point) which are also important considering the similarities in the toxicological profiles and the toxicokinetic behaviour as well as the relevant exposure routes of the substance.

Based on the content of saturated, olefinic and aromatic hydrocarbons, the typical carbon number range and the physicochemical properties, the renewable hydrocarbons with gasoline type fractions can be considered as having structural similarities and similar behaviour in contact with water and in the physiological processes than the analogue source substances (fossil gasolines). Their irritation and skin sensitisation as well as acute and long-term adverse effects to human health is similar. Therefore, and in order to avoid the unnecessary animal testing, the read-across data from the analogue fossil gasolines is used to evaluate the irritation, senstisation and short term and/or long-term toxicological effects of the target substance.

Reason / purpose for cross-reference:

read-across source

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.3465 (90-Day Inhalation Toxicity)

GLP compliance:

yes

Limit test:

no

Species:

rat

Strain:

Sprague-Dawley

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Charles River Laboratories, Kingston, NY 12484
- Age at study initiation: ~ 4-6 weeks
- Weight at study initiation: Male: 294.5 g; Female: 201.5 g
- Housing: Individually in stainless steel wire mesh cages
- Diet (e.g. ad libitum): Available without restriction
- Water (e.g. ad libitum): Available without restriction
- Acclimation period: at least 16 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 15-26
- Humidity (%): 12-79
- Photoperiod (hrs dark / hrs light): 12/12

Route of administration:

inhalation: vapour

Type of inhalation exposure:

whole body

Vehicle:

other: unchanged (no vehicle)

Details on inhalation exposure:

GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: 1 m^3 glass and stainless steel exposure chamber
- Method of conditioning air: Houseline nitrogen was delivered from a regulator with a backpressure gauge through a stainless steel fitting to create three flow systems: the test substance pressurization flow, the purge flow and the volatilization flow. As the test substance laden nitrogen was drawn into each of the chambers, it was mixed with room air.
- Air flow rate: 200 L/min
- Air change rate: 12 air changes/hour
- Treatment of exhaust air: The chambers were exhausted through the in house filtering system, which consisted of a coarse filter, a HEPA filter, activated charcoal and then through a fume incinerator.

TEST ATMOSPHERE
- Brief description of analytical method used: During each exposure, measurements of airborne concentrations were performed in the animals' breathing zone at least 4 times using an appropriate sampling procedure and infrared spectrophotometric analytical procedure. Also, one charcoal tube sample was collected per chamber per week and analyzed by GC to characterize at least 10 major components to show test substance stability and comparison between the neat liquid test substance and the vaporized test atmospheres.
- Samples taken from breathing zone: yes

Analytical verification of doses or concentrations:

yes

Details on analytical verification of doses or concentrations:

Infrared spectrophotometric sampling and one charcoal tube sample was collected per chamber per week and analyzed by gas chromatography.

Duration of treatment / exposure:

13 weeks

Frequency of treatment:

6 hours/day; 5 days/week

Remarks:

Doses / Concentrations:
2050 mg/m³ (2000 mg/m³)
Basis:
analytical conc.

Remarks:

Doses / Concentrations:
10148 mg/m³ (10000 mg/m³)
Basis:
analytical conc.

Remarks:

Doses / Concentrations:
20324 mg/m³ (20000 mg/m³)
Basis:
analytical conc.

No. of animals per sex per dose:

Group 1 (control): 20 males and 20 females
Group 2 (low): 10 males and 10 females
Group 3 (mid): 10 males and 10 females
Group 4 (high): 20 males and 20 females

Control animals:

yes, sham-exposed

Observations and examinations performed and frequency:

CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Twice daily for mortality and signs of severe toxic or pharmacologic effects.

DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: All animals were observed as a group at least once during each exposure. Each animal was removed from its cage and examined twice pretest and once weekly during the study period. Examinations included observations of general condition, skin and fur, eyes, nose, oral cavity, abdomen and external genitalia as well as evaluations of respiration, palpation for tissue masses, circulatory effects, autonomic effects, central nervous system effects, changes in motor activity, and reactivity to handling or sensory stimuli.

BODY WEIGHT: Yes
- Time schedule for examinations: Animals were removed from their cages and weighed twice pretest, weekly during treatment and terminally. Terminal, fasted body weights were obtained just prior to necropsy.

FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes

FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No

WATER CONSUMPTION: No

OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: Pretest and at study termination
- Dose groups that were examined: All animals except Genotox and Immunotox animals

HAEMATOLOGY: Yes
- Time schedule for collection of blood: Interim (~ 4 weeks) and Terminal intervals
- Anaesthetic used for blood collection: Yes - carbon dioxide/oxygen; 60%/40%
- Animals fasted: Yes
- Parameters checked in table were examined.

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: 4th week interval
- Animals fasted: Yes
- How many animals: All animals
- Parameters checked in table were examined.

NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: Testing was staggered over several sessions and was conducted on non-exposure days or at least 16 hours post-exposure.
- Dose groups that were examined: 10 animals/sex/exposure group
- Battery of functions tested: grip strength / Home cage evaluations/ handling evaluations/ open field evaluations/ reflex assessments/ landing foot splay/ hindlimb extensor strength/ air righting ability/ body weight/ motor activity/ sensory activity

OTHER: Genotoxicity evaluations and Immunotoxicity evaluations

Sacrifice and pathology:

GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes

Statistics:

The following parameters were analyzed statistically:

mean body weight values and body weight changes (from pretest)
mean feed consumption values (presented as grams of feed/kg of body weight/day)
mean clinical laboratory values
mean organ weights, organ/body weight ratios and organ/brain weight ratios
mean motor activity counts
mean FOB data including forelimb and hindlimb grip strength measurements and mean landing foot splay measurements

Appropriate statistional methods of analysis were conducted.

Clinical signs:

no effects observed

Mortality:

no mortality observed

Body weight and weight changes:

no effects observed

Food consumption and compound intake (if feeding study):

no effects observed

Food efficiency:

not specified

Water consumption and compound intake (if drinking water study):

not specified

Ophthalmological findings:

no effects observed

Haematological findings:

no effects observed

Clinical biochemistry findings:

no effects observed

Urinalysis findings:

not specified

Behaviour (functional findings):

no effects observed

Organ weight findings including organ / body weight ratios:

no effects observed

Gross pathological findings:

no effects observed

Histopathological findings: non-neoplastic:

effects observed, treatment-related

Histopathological findings: neoplastic:

not specified

Details on results:

CLINICAL SIGNS AND MORTALITY: There was one death and it was considered not treatment-related. The test animals were unremarkable during the exposure periods. A slight increase in red nasal discharge was seen in the 20000 mg/m^3 exposed animals during the 3rd through the 7th weeks of exposures but not during the 4 week recovery period. The effect is considered localized to the site of application of test material.


BODY WEIGHT AND WEIGHT GAIN: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

FOOD CONSUMPTION: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

HAEMATOLOGY: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

CLINICAL CHEMISTRY: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

NEUROBEHAVIOUR: The results of the analyses did not indicate a statistically significant exposure-related effect.

ORGAN WEIGHTS: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

GROSS PATHOLOGY: No gross abnormalities related to test substance exposure were evident on necropsy examination.

HISTOPATHOLOGY: NON-NEOPLASTIC: Microscopic findings that were considered treatment-related were only found in the nasal turbinates of male and female animals and the kidneys of male animals.

Nasal turbinates: Male and female rats exposed to 20000 mg/m^3 had eosinophilic material within the nasolacrimal duct lumen which correlates with the increase in red nasal discharge noted previously.

Kidneys: Male rats exposed to all three dose levels had eosinophilic hyaline granules within the cytoplasm of renal proximal convoluted tubular epithelial cells. The degree of cytoplasmic granulation varied in an exposure-level dependent manner.

Dose descriptor:

NOAEC

Remarks:

systemic effects

Effect level:

> 20 000 mg/m³ air

Sex:

male/female

Basis for effect level:

other: (exclusive of male hydrocarbon nephropathy)

Dose descriptor:

NOAEC

Remarks:

local effects

Effect level:

10 000 mg/m³ air

Sex:

male/female

Basis for effect level:

other: (red nasal discharge at sign of contact)

Critical effects observed:

not specified

Conclusions:

Toxicity of read-across substance, baseline gasoline condensate, was investigated in a suchronic 90-day inhalation study in rats. The test substance was administered at analytical vapor concentrations of 2000, 10 000, and 20 000 mg/m³. Based on the study results the systemic NOAEC was established to be greater than 20 000 mg/m3 and the local NOAEC was established at 10 000 mg/m3.

Executive summary:

Baseline gasoline vapor condensate was administered by inhalation to Sprague-Dawley rats for 6 hours/day, 5 days/week for 13 weeks at analytical vapor concentrations of 2000, 10 000, and 20 000 mg/m³ in order to assess subchronic inhalation toxicity. No animals died due to the administration of test material. There were no effects on body weight gain, organ weights, hematology and chemical chemistry analyses, gross pathology or neurobehavior. Microscopic findings that were considered treatment-related were only found in the nasal turbinates of male and female animals and the kidneys of male animals.13 weeks of exposure of rats to the test substance resulted in slight yet reversible increases in red nasal discharge in animals exposed to 20 000 mg/m³ of vapor. All exposure levels were also associated with hydrocarbon nephropathy in male rats. However, this finding has been generally accepted not to be relevant to human risk assessment. If the red nasal discharge is considered irritation at the site of contact, the systemic NOAEC is determined to be greater than 20 000 mg/m3, and the local NOAEC is 10 000 mg/m3.

This study is considered reliable with restrictin the report is acceptable, well-documented and similar or equivalent to OECD 413 and conducted according to the GLP, but performed using the read-across substance.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

NOAEC

20 000 mg/m³

Study duration:

subchronic

Species:

rat

Repeated dose toxicity: inhalation - local effects

Link to relevant study records

Reference

Endpoint:

sub-chronic toxicity: inhalation

Type of information:

read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

weight of evidence

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: see 'Remark'

Remarks:

Acceptable, well-documented study report similar or equivalent to OECD 413 conducted according to the GLP, but conducted for the read-across substance. Read-across justification: Based on the chemical composition, the renewable hydrocarbons obtained from the catalytic hydrotreatment of wood oil with or without the addition of vegetable oils and/or animal fats have similar hydrocarbon fractions and they contain the same critical constituents than fossil fuels (low boiling naphthas). Naphtha is a generic term used to describe volatile, flammable hydrocarbon fractions. The target substance and the sources substances (naphthas) meet same physical-chemical and technical performance specifications in Europe (EN 228). These fuel specifications include limits for the certain properties (vapour pressure and boiling point) which are also important considering the similarities in the toxicological profiles and the toxicokinetic behaviour as well as the relevant exposure routes of the substance. Based on the content of saturated, olefinic and aromatic hydrocarbons, the typical carbon number range and the physicochemical properties, the renewable hydrocarbons with gasoline type fractions can be considered as having structural similarities and similar behaviour in contact with water and in the physiological processes than the analogue source substances (fossil gasolines). Their irritation and skin sensitisation as well as acute and long-term adverse effects to human health is similar. Therefore, and in order to avoid the unnecessary animal testing, the read-across data from the analogue fossil gasolines is used to evaluate the irritation, sensitisation and short term and/or long-term toxicological effects of the target substance.

Justification for type of information:

Based on the chemical composition, the renewable hydrocarbons obtained from the catalytic hydrotreatment of wood oil with or without the addition of vegetable oils and/or animal fats have similar hydrocarbon fractions and they contain the same critical constituents than fossil fuels (low boiling naphthas). Naphtha is a generic term used to describe volatile, flammable hydrocarbon fractions. The target substance and the sources substances (naphthas) meet same physical-chemical and technical performance specifications in Europe (EN 228). These fuel specifications include limits for the certain properties (vapour pressure and boiling point) which are also important considering the similarities in the toxicological profiles and the toxicokinetic behaviour as well as the relevant exposure routes of the substance.

Based on the content of saturated, olefinic and aromatic hydrocarbons, the typical carbon number range and the physicochemical properties, the renewable hydrocarbons with gasoline type fractions can be considered as having structural similarities and similar behaviour in contact with water and in the physiological processes than the analogue source substances (fossil gasolines). Their irritation and skin sensitisation as well as acute and long-term adverse effects to human health is similar. Therefore, and in order to avoid the unnecessary animal testing, the read-across data from the analogue fossil gasolines is used to evaluate the irritation, senstisation and short term and/or long-term toxicological effects of the target substance.

Reason / purpose for cross-reference:

read-across source

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.3465 (90-Day Inhalation Toxicity)

GLP compliance:

yes

Limit test:

no

Species:

rat

Strain:

Sprague-Dawley

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Charles River Laboratories, Kingston, NY 12484
- Age at study initiation: ~ 4-6 weeks
- Weight at study initiation: Male: 294.5 g; Female: 201.5 g
- Housing: Individually in stainless steel wire mesh cages
- Diet (e.g. ad libitum): Available without restriction
- Water (e.g. ad libitum): Available without restriction
- Acclimation period: at least 16 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 15-26
- Humidity (%): 12-79
- Photoperiod (hrs dark / hrs light): 12/12

Route of administration:

inhalation: vapour

Type of inhalation exposure:

whole body

Vehicle:

other: unchanged (no vehicle)

Details on inhalation exposure:

GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: 1 m^3 glass and stainless steel exposure chamber
- Method of conditioning air: Houseline nitrogen was delivered from a regulator with a backpressure gauge through a stainless steel fitting to create three flow systems: the test substance pressurization flow, the purge flow and the volatilization flow. As the test substance laden nitrogen was drawn into each of the chambers, it was mixed with room air.
- Air flow rate: 200 L/min
- Air change rate: 12 air changes/hour
- Treatment of exhaust air: The chambers were exhausted through the in house filtering system, which consisted of a coarse filter, a HEPA filter, activated charcoal and then through a fume incinerator.

TEST ATMOSPHERE
- Brief description of analytical method used: During each exposure, measurements of airborne concentrations were performed in the animals' breathing zone at least 4 times using an appropriate sampling procedure and infrared spectrophotometric analytical procedure. Also, one charcoal tube sample was collected per chamber per week and analyzed by GC to characterize at least 10 major components to show test substance stability and comparison between the neat liquid test substance and the vaporized test atmospheres.
- Samples taken from breathing zone: yes

Analytical verification of doses or concentrations:

yes

Details on analytical verification of doses or concentrations:

Infrared spectrophotometric sampling and one charcoal tube sample was collected per chamber per week and analyzed by gas chromatography.

Duration of treatment / exposure:

13 weeks

Frequency of treatment:

6 hours/day; 5 days/week

Remarks:

Doses / Concentrations:
2050 mg/m³ (2000 mg/m³)
Basis:
analytical conc.

Remarks:

Doses / Concentrations:
10148 mg/m³ (10000 mg/m³)
Basis:
analytical conc.

Remarks:

Doses / Concentrations:
20324 mg/m³ (20000 mg/m³)
Basis:
analytical conc.

No. of animals per sex per dose:

Group 1 (control): 20 males and 20 females
Group 2 (low): 10 males and 10 females
Group 3 (mid): 10 males and 10 females
Group 4 (high): 20 males and 20 females

Control animals:

yes, sham-exposed

Observations and examinations performed and frequency:

CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Twice daily for mortality and signs of severe toxic or pharmacologic effects.

DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: All animals were observed as a group at least once during each exposure. Each animal was removed from its cage and examined twice pretest and once weekly during the study period. Examinations included observations of general condition, skin and fur, eyes, nose, oral cavity, abdomen and external genitalia as well as evaluations of respiration, palpation for tissue masses, circulatory effects, autonomic effects, central nervous system effects, changes in motor activity, and reactivity to handling or sensory stimuli.

BODY WEIGHT: Yes
- Time schedule for examinations: Animals were removed from their cages and weighed twice pretest, weekly during treatment and terminally. Terminal, fasted body weights were obtained just prior to necropsy.

FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes

FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No

WATER CONSUMPTION: No

OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: Pretest and at study termination
- Dose groups that were examined: All animals except Genotox and Immunotox animals

HAEMATOLOGY: Yes
- Time schedule for collection of blood: Interim (~ 4 weeks) and Terminal intervals
- Anaesthetic used for blood collection: Yes - carbon dioxide/oxygen; 60%/40%
- Animals fasted: Yes
- Parameters checked in table were examined.

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: 4th week interval
- Animals fasted: Yes
- How many animals: All animals
- Parameters checked in table were examined.

NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: Testing was staggered over several sessions and was conducted on non-exposure days or at least 16 hours post-exposure.
- Dose groups that were examined: 10 animals/sex/exposure group
- Battery of functions tested: grip strength / Home cage evaluations/ handling evaluations/ open field evaluations/ reflex assessments/ landing foot splay/ hindlimb extensor strength/ air righting ability/ body weight/ motor activity/ sensory activity

OTHER: Genotoxicity evaluations and Immunotoxicity evaluations

Sacrifice and pathology:

GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes

Statistics:

The following parameters were analyzed statistically:

mean body weight values and body weight changes (from pretest)
mean feed consumption values (presented as grams of feed/kg of body weight/day)
mean clinical laboratory values
mean organ weights, organ/body weight ratios and organ/brain weight ratios
mean motor activity counts
mean FOB data including forelimb and hindlimb grip strength measurements and mean landing foot splay measurements

Appropriate statistional methods of analysis were conducted.

Clinical signs:

no effects observed

Mortality:

no mortality observed

Body weight and weight changes:

no effects observed

Food consumption and compound intake (if feeding study):

no effects observed

Food efficiency:

not specified

Water consumption and compound intake (if drinking water study):

not specified

Ophthalmological findings:

no effects observed

Haematological findings:

no effects observed

Clinical biochemistry findings:

no effects observed

Urinalysis findings:

not specified

Behaviour (functional findings):

no effects observed

Organ weight findings including organ / body weight ratios:

no effects observed

Gross pathological findings:

no effects observed

Histopathological findings: non-neoplastic:

effects observed, treatment-related

Histopathological findings: neoplastic:

not specified

Details on results:

CLINICAL SIGNS AND MORTALITY: There was one death and it was considered not treatment-related. The test animals were unremarkable during the exposure periods. A slight increase in red nasal discharge was seen in the 20000 mg/m^3 exposed animals during the 3rd through the 7th weeks of exposures but not during the 4 week recovery period. The effect is considered localized to the site of application of test material.


BODY WEIGHT AND WEIGHT GAIN: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

FOOD CONSUMPTION: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

HAEMATOLOGY: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

CLINICAL CHEMISTRY: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

NEUROBEHAVIOUR: The results of the analyses did not indicate a statistically significant exposure-related effect.

ORGAN WEIGHTS: There were no toxicologically significant differences in the test substance exposed animals compared to the control animals.

GROSS PATHOLOGY: No gross abnormalities related to test substance exposure were evident on necropsy examination.

HISTOPATHOLOGY: NON-NEOPLASTIC: Microscopic findings that were considered treatment-related were only found in the nasal turbinates of male and female animals and the kidneys of male animals.

Nasal turbinates: Male and female rats exposed to 20000 mg/m^3 had eosinophilic material within the nasolacrimal duct lumen which correlates with the increase in red nasal discharge noted previously.

Kidneys: Male rats exposed to all three dose levels had eosinophilic hyaline granules within the cytoplasm of renal proximal convoluted tubular epithelial cells. The degree of cytoplasmic granulation varied in an exposure-level dependent manner.

Dose descriptor:

NOAEC

Remarks:

systemic effects

Effect level:

> 20 000 mg/m³ air

Sex:

male/female

Basis for effect level:

other: (exclusive of male hydrocarbon nephropathy)

Dose descriptor:

NOAEC

Remarks:

local effects

Effect level:

10 000 mg/m³ air

Sex:

male/female

Basis for effect level:

other: (red nasal discharge at sign of contact)

Critical effects observed:

not specified

Conclusions:

Toxicity of read-across substance, baseline gasoline condensate, was investigated in a suchronic 90-day inhalation study in rats. The test substance was administered at analytical vapor concentrations of 2000, 10 000, and 20 000 mg/m³. Based on the study results the systemic NOAEC was established to be greater than 20 000 mg/m3 and the local NOAEC was established at 10 000 mg/m3.

Executive summary:

Baseline gasoline vapor condensate was administered by inhalation to Sprague-Dawley rats for 6 hours/day, 5 days/week for 13 weeks at analytical vapor concentrations of 2000, 10 000, and 20 000 mg/m³ in order to assess subchronic inhalation toxicity. No animals died due to the administration of test material. There were no effects on body weight gain, organ weights, hematology and chemical chemistry analyses, gross pathology or neurobehavior. Microscopic findings that were considered treatment-related were only found in the nasal turbinates of male and female animals and the kidneys of male animals.13 weeks of exposure of rats to the test substance resulted in slight yet reversible increases in red nasal discharge in animals exposed to 20 000 mg/m³ of vapor. All exposure levels were also associated with hydrocarbon nephropathy in male rats. However, this finding has been generally accepted not to be relevant to human risk assessment. If the red nasal discharge is considered irritation at the site of contact, the systemic NOAEC is determined to be greater than 20 000 mg/m3, and the local NOAEC is 10 000 mg/m3.

This study is considered reliable with restrictin the report is acceptable, well-documented and similar or equivalent to OECD 413 and conducted according to the GLP, but performed using the read-across substance.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

NOAEC

10 000 mg/m³

Study duration:

subchronic

Species:

rat

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion

Endpoint conclusion:

no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion

Endpoint conclusion:

no study available

Additional information

No study was conducted since there is enough evidence on repeated dose toxicity on the identified critical ingredients of the substance and read-across data on fossil gasoline. This UVCB substance is a complex mixture of hydrocarbons. When there is no data on the substance itself the read-across data was also used to avoid unnecessary animal testing. The read-across from fossil gasoline is justified because the toxicokinetics and toxicological properties of renewable gasoline are considered similar to fossil gasoline based on the similar composition and physical-chemical properties. The read-across justification and the data matrices are presented in annex 1 of the CSR.

Using a read-across approach, a repeated dose inhalation toxicity study was identified for baseline gasoline condensate. Read-across data after repeated inhalation exposure is used for hazard assessment, since the inhalation route is considered the most relevant route of human exposure.Toxicity of baseline gasoline vapour condensate was investigated in a subchronic 90-day inhalation study in rats (API, 2005). The test substance was administered by inhalation to Sprague-Dawley rats for 6 hours/day, 5 days/week for 13 weeks at analytical vapour concentrations of 2000, 10 000 and 20 000 mg/m³. No animals died due to the administration of test material. There were no effects on body weight gain, organ weights, haematology and chemical chemistry analyses, gross pathology or neurobehaviour. Microscopic findings that were considered treatment-related were only found in the nasal turbinates of male and female animals and the kidneys of male animals. 13 weeks of exposure of rats to the test substance resulted in slight yet reversible increases in red nasal discharge in animals exposed to 20 000 mg/m³ of vapor. All exposure levels were also associated with hydrocarbon nephropathy in male rats. However, this finding has been generally accepted not to be relevant to human risk assessment. If the red nasal discharge is considered irritation at the site of contact, the systemic NOAEC is determined to be greater than 20,000 mg/m³, and the local NOAEC is 10 000 mg/m³. The results of this study do not support the STOT-RE classification for renewable hydrocarbons of wood origin (naphtha type fraction).

This substance contains following substances having harmonised classification, n-hexane (< 5 %), toluene (< 5 %) and benzene (< 1 %). n-Hexane is classified toxic after repeated exposure with harmonized C&L entry of STOT-RE 2 H373. The specific limit value of n-hexane in CLP regulation which triggers the classification of mixtures to hazard class STOT-RE2 is ≥ 5 %. Generic concentration limit for STOT-RE2 classification applies to toluene. The generic limit value of individual substance in CLP regulation triggering the classification of mixtures to repeated toxicity is ≥ 5 %.Benzene has harmonised classification for STOT-RE1. Based on the CLP mixtures rules the general concentration limit c ≥ 1 % would trigger the classification of mixture to STOT-RE2.

Based on the CLP mixture rules, no classification for repeated dose toxicity is warranted to renewable hydrocarbons of wood origin (naphtha type fraction) based on CLP mixture rules.

Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
No study conducted for the substance and no studies available for the read-across substances. The conclusions on the toxicity after repeated dose is done based on the CLP mixture rules and harmonised classifications of the components in this UVCB substance.

Justification for selection of repeated dose toxicity inhalation - systemic effects endpoint:
No study conducted for the substance. The selected study is from the read-across studies conducted for baseline gasoline condensate.

Justification for selection of repeated dose toxicity inhalation - local effects endpoint:
No study conducted for the substance. The selected study is from the read-across studies conducted for baseline gasoline condensate.

Justification for selection of repeated dose toxicity dermal - systemic effects endpoint:
No study conducted for the substance and no studies available for the read-across substances. The conclusions on the toxicity after repeated dose is done based on the CLP mixture rules and harmonised classifications of the components in this UVCB substance. Hazard threshold values for dermal effects are derived based on the BOELV(inhalation) of the most hazardous constituent (bentzene) of this substance.

Justification for selection of repeated dose toxicity dermal - local effects endpoint:
No study conducted for the substance and no studies available for the read-across substances.

Justification for classification or non-classification

No classification for repeated dose toxicity for renewable hydrocarbons of wood origin (naphtha type fraction) is warranted. The classification conclusion is based on the read-across data to baseline gasoline condensate after inhalation exposure (API, 2005) and the harmonised classification entries of the critical constituents in this substance.